Summit Therapeutics Inc.
SMMTCIK 0001599298 · Every Form 4 filed by insiders at this issuer.
Filings
8
Latest Mar 27, 2024
Unique insiders
8
Showing
8 of 8
Page 1
Top insiders
Most active reporters at Summit Therapeutics Inc.
| Name | Roles | Filings |
|---|---|---|
| Booth Robert F. | Director | 1 |
| Cesano Alessandra | Director | 1 |
| Clark Kenneth A | Director | 1 |
| DUGGAN ROBERT W | OfficerDirector10% Owner | 1 |
| Dhingra Ankur | Officer | 1 |
| Mahatme Ujwala | Director | 1 |
| Xia Yu | Director | 1 |
| Zanganeh Mahkam | OfficerDirector | 1 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 27, 2024 | Dhingra Ankur Chief Financial Officer | P | 100,000 | $3.75 | $375,000 | |
| Mar 27, 2024 | Zanganeh Mahkam Chief Executive Officer · Director | P | 34,321 | $3.72 | $127,674 | |
| Jan 4, 2024 | DUGGAN ROBERT W Co-Chief Executive Officer · Director · 10% Owner | Holdings only | — | — | — | |
| Jan 4, 2024 | Xia Yu Director | Holdings only | — | — | — | |
| Jan 4, 2024 | Mahatme Ujwala Director | Holdings only | — | — | — | |
| Jan 4, 2024 | Clark Kenneth A Director | Holdings only | — | — | — | |
| Jan 4, 2024 | Booth Robert F. Director | Holdings only | — | — | — | |
| Jan 4, 2024 | Cesano Alessandra Director | Holdings only | — | — | — |
Showing 1–8 of 8
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.